Literature DB >> 15241616

Long-term fate of uncemented, threaded acetabular components with smooth surface treatment: minimum 10-year follow-up of two different designs.

Peter R Aldinger1, Marc Thomsen, Martin Lukoschek, Hans Mau, Volker Ewerbeck, Steffen J Breusch.   

Abstract

INTRODUCTION: In the 1970s and 1980s, uncemented, threaded acetabular components with smooth surface treatment were widely used in continental Europe for arthroplasty of the hip to overcome the high rate of aseptic loosening in cemented hip arthroplasty in young patients. There were several reports on short- and intermediate-term results, but information on survival in the longer term is not available at present.
MATERIALS AND METHODS: In a consecutive series of 320 patients, 348 threaded cups with smooth surface treatment (221 Mecring and 127 Weill) had been implanted in combination with one type of uncemented stem. Patients were followed clinically and radiographically. The mean time of follow-up was 12.4 (range 10-15) years (Mecring 11.9 years, Weill 13.3 years).
RESULTS: In 76 hips the acetabular component had been revised (Mecring 56, Weill 20): 7 hips for infection and 69 for aseptic loosening. Of the remainder, the cup had migrated in 55 hips, and 32 hips were awaiting revision. Survival at 14 years was 63.8% (95%CI: 52.5-75.0%) for the Mecring and 76.2% (95%CI: 65.6-86.7%) for the Weill component. Radiolucent lines were present in 59 hips (31.9%). The median Harris Hip Score at follow-up was 84 points (Mecring 85, Weill 82). Radiographic loosening did not correlate with clinical outcome.
CONCLUSION: These results support the view that smooth, threaded acetabular components do not provide satisfactory long-term fixation and should be abandoned.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241616     DOI: 10.1007/s00402-004-0709-y

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  8 in total

1.  Survival of the cementless Spotorno stem in the second decade.

Authors:  Peter R Aldinger; Alexander W Jung; Steffen J Breusch; Volker Ewerbeck; Dominik Parsch
Journal:  Clin Orthop Relat Res       Date:  2009-06-06       Impact factor: 4.176

2.  Long-term results of the Wagner conical screw cup.

Authors:  Alexander Schuh; Annemarie Schraml; Gerd Hohenberger
Journal:  Int Orthop       Date:  2008-06-26       Impact factor: 3.075

3.  [Five-year survival rate of the Allofit titanium press-fit cup].

Authors:  K Schroeder; A Moehlenbruch; M Zimmermann-Stenzel; D Parsch
Journal:  Orthopade       Date:  2010-01       Impact factor: 1.087

4.  Thirteen year follow-up of a cementless femoral stem and a threaded acetabular cup in patients younger than fifty years of age.

Authors:  Jan Schmolders; Grigoris Amvrazis; Peter H Pennekamp; Andreas Christian Strauss; Max Julian Friedrich; Matthias D Wimmer; Yorck Rommelspacher; Dieter Christian Wirtz; Thomas Wallny
Journal:  Int Orthop       Date:  2016-05-30       Impact factor: 3.075

5.  A long-term follow-up of 60 Lord total hip arthroplasties in rheumatic disease: a mean follow-up of 14 years.

Authors:  C C Lybäck; C O Lybäck; A Kyrö; H J Kautiainen; E A Belt
Journal:  Int Orthop       Date:  2006-05-12       Impact factor: 3.075

6.  Long-term results of the threaded Mecron cup in primary total hip arthroplasty : A 15-20-year follow-up study.

Authors:  Michael Clarius; Alexander W Jung; Marcus R Streit; Christian Merle; Patric Raiss; Peter R Aldinger
Journal:  Int Orthop       Date:  2009-07-24       Impact factor: 3.075

7.  Long-term results of the threaded Weill cup in primary total hip arthroplasty: a 15-20-year follow-up study.

Authors:  Michael Clarius; Alexander W Jung; Patric Raiss; Marcus R Streit; Christian Merle; Peter R Aldinger
Journal:  Int Orthop       Date:  2009-07-24       Impact factor: 3.075

8.  Failure of Polyethylene Inlays in Cementless Total Hip Arthroplasty: A Retrieval Analysis.

Authors:  Ulrike Mueller; Christoph Lee; Christian Heisel; Marc Thomsen; Rudi G Bitsch; J Philippe Kretzer
Journal:  Biomed Res Int       Date:  2016-08-31       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.